EcoDrugPlus

Catechol-O-Methyltransferase

Ensembl ID : ENSHBUG00000014357
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSHBUG00000014011
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin E

Ensembl ID : ENSHBUG00000006331
Gene Symbol: CTSE
3 Cross references
219 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSHBUG00000014890
Gene Symbol: LOC102291643
3 Cross references
222 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSHBUG00000014918
Gene Symbol: CTSS
2 Cross references
227 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSHBUG00000014897
Gene Symbol: CTSS
4 Cross references
229 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSHBUG00000001992
Gene Symbol: LOC102290157
2 Cross references
183 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSHBUG00000007322
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Cellular Tumor Antigen P53-Like

Ensembl ID : ENSHBUG00000002345
Gene Symbol: LOC102296334
2 Cross references
232 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSHBUG00000015979
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSHBUG00000019743
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSHBUG00000020229
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).